Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
Cardio-oncology refers to a clinical subspecialty that is focused on understanding, managing, and treating the possible cardiac side effects—known as cardio toxicity—of cancer treatments such as chemotherapy and radiation therapy. Over the past few years, cardio-oncology clinics have sprung up in major medical centers across the nation to provide integrated and interdisciplinary care to cancer patients with cardiovascular risks. Most cardio-oncologists are cardiologists who have a special interest and often special training in the cardiac effects of cancer treatments.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
In medicine, Asystole colloquially known as flatline, is a state of no cardiac electrical activity, hence no contractions of the myocardium and any cardiac output or blood flow. Asystole is one of the conditions that may be used for a medical practitioner to certify clinical or legal death. Asystole is treated by Cardiopulmonary resuscitation (CPR) combined with an intravenous vasopressor such as epinephrine (adrenaline). Sometimes an underlying reversible cause can be detected and treated (the so-called 'H's and T's', an example of which is hypokalaemia). Several interventions previously recommended—such as defibrillation (known to be ineffective on asystole, but previously performed in case the rhythm is actually fine ventricular fibrillation) and intravenousatropine is no longer part of the routine protocols recommended by most major international bodies. Asystole may be treated with 1 mg epinephrine by IV every 3-5 minutes as needed. Vasopressin 40 units by IV every 3-5 minutes may be used in place of the first and/or second doses of epinephrine, but doing so does not enhance outcomes.
In medicine, Asystole colloquially known as flatline , is a state of no cardiac electrical activity, hence no contractions of the myocardium and no cardiac output or blood flow. Asystole is one of the conditions that may be used for a medical practitioner to certify clinical or legal death. Asystole is treated by cardiopulmonary resuscitation (CPR) combined with an intravenous vasopressor such as epinephrine (adrenaline). Sometimes an underlying reversible cause can be detected and treated (the so-called 'H's and T's', an example of which is hypokalaemia). Several interventions previously recommended—such as defibrillation (known to be ineffective on asystole, but previously performed in case the rhythm is actually fine ventricular fibrillation) and intravenous atropine—are no longer part of the routine protocols recommended by most major international bodies. Asystole may be treated with 1 mg epinephrine by IV every 3-5 minutes as needed. Vasopressin 40 units by IV every 3-5 minutes may be used in place of the first and/or second doses of epinephrine, but doing so does not enhance outcomes.
Survival rates in a cardiac arrest patient with asystole are much lower than a patient with a rhythm amenable to defibrillation; asystole is itself not a "shockable" rhythm. Out-of-hospital survival rates (even with emergency intervention) are less than 2 percent. Electrical defibrillation should not be applied indiscriminately to the patient in asystole. This is not only fruitless, but also detrimental, eliminating any possibility of recovering a rhythm. Asystole following electrical defibrillation has an even worse outcome than that in a patient whose first documented rhythm was asystole. One caution is that, following defibrillation, a brief spurious asystole can occur using manual monitoring through the defibrillator paddles. This does not occur with the rhythm monitoring leads or hands-off monitor pads. If not taken into consideration, it could lead to a delay in defibrillation, when indeed VF is present.The ventricular recovery from Asystole or EMD is possible if the heart is subsequently perfused at normal pressures with O2 saturated solution. Sudden cardiac death (SCD) takes up to 500,000 lives each year before a victim can even be treated. To address this implantable cardioverter defibrillator (ICD) was developed to treat those identified at high risk of SCD. Unfortunately, there are a significant number of cases in which the ICD does not successfully return a victim to normal rhythm and effective perfusion of the blood. Immediate diagnosis of Asystole requires the recognition of a full cardiac arrest and a confirmed flat-line rhythm in 2 perpendicular leads. Light-headedness or syncope may precede Asystole when it follows a bradyasystolic rhythm. Sometime Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide.
According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases. Major factors driving the global cardiac equipment market are, rising geriatric population along with higher incidence of coronary artery diseases, stroke, heart failure, hypertension and diabetes.
List of Best International Conferences:
1. 6th Clinical Cardiology Conference November 30-December 02, 2015 San Antonio, USA
2. 7th Cardiothoracic Conference March 29-30, 2016 Atlanta, USA
3. 8th Cardiologists Conference July 18-20, 2016 Berlin, Germany
4. Cardiac Nursing Conference May 5-7, 2016 Chicago, USA
5. 2nd Pediatric Cardiology Conference September 22-24, 2016, Las Vegas, USA
6. Transplantation Conference March 28-29, 2016 Atlanta, USA
7. 4th Healthcare Conference July 18-20, 2016 Brisbane, Australia
8. Healthcare Conference November 09-11, 2015 Dubai, UAE
9. 8th Healthcare Conference October 13-15, 2016 Dubai, UAE
10. 6th Healthcare and Fitness Conference August 22-24, 2016 Philadelphia, USA
11. Healthcare Conference October 05-07, 2015 New Delhi, India
12. Hypertension Conference, Aug 4-6, 2016, Toronto, Canada
13. 10th Interventional Cardiology Conference, Sept 12-14, 2016, Berlin, Germany
14. Cardiovascular Imaging Conference, Nov 7-9, 2016, Istanbul, Turkey
15. Angiology Conference Dec 8-10, 2016,San Antonio, USA
16. Internal Medicine Conference, November 03-05, 2016 Baltimore, Maryland, USA
17. Anesthesia and Intensive Care conference September 12-14, 2016 Phoenix, Arizona, USA
18. 4th Surgery Conference October 05-07, 2015 Crowne Plaza, Dubai, UAE
19. 5th Surgery Conference October 06-08, 2016 Alicante, Spain
20. 2nd Pain Medicine Conference May 16-18, 2016 San Antonio, USA
21. Hospice and Palliative Care Conference August 31-September 02, 2015 Orlando, USA
22. 2nd Hospice and Palliative Care Conference August 25-27, 2016 Philadelphia, USA
23. Hypertrophic Cardiomyopathy: A Contemporary Treatable Disease - International Summit, September 27-29, 2015,Minneapolis, , USA
24. The 4th International Congress on Cardiac Problems in Pregnancy, 27 February-1 March,2016 Lavagas, USA
25. International Clinical Cardiovascular Genetics Conference 2016, 25-27 March 2016, Brisbane,Australia
26. Cardiac Development, Regeneration and Repair, April 3—7, 2016, Snowbird Resort, Snowbird, Utah, USA
27. Autophagy in Stress, Development & Disease, March 20-25, 2016, Ventura, CA
Relevant Society and Associations
1. European Society of Cardiology
2. Canadian Society of Echocardiography
3. Society of Thoracic surgeons
4. The American Society for Preventive Cardiology
5. Russian Society of Cardiology
6. European Society of Cardiology
7. Cardiological Society of India
8. ESC National Cardiac Societies
9. British Cardiovascular Society
10. AEPC Association for European Paediatric Cardiology
11. The International Society of Cardiology
12. Canadian Cardiovascular Society
13. American College of Cardiology
14. Coeliac Society of Ireland
15. Korean Society of Cardiology
16. Caribbean Cardiac Society
17. British Cardiovascular Intervention Society
18. Pediatric Interventional Cardiology Early Career Society
19. American Heart Association
20. World Heart Federation
1. Coloplast A/S
2. B. Braun Melsungen AG
3. Paul Hartmann AG
4. ConvaTec Healthcare B S.a.r.l.
5. Molnlycke Health Care AB
6. 3M Health Care Ltd.
7. Huntleigh Healthcare Ltd
8. Smith & Nephew Plc
9. Systagenix Wound Management, Limited
10. Solvay SA
11. Novozymes A/S
12. Total S.A.
13. BASF SE
14. Bayer AG
15. Clariant International AG
16. Celanese Corporation
17. E. I. du Pont de Nemours and Company
18. The Dow Chemical Company
19. Baxter International Inc.
20. BSN medical, Inc.
21. Ethicon, Inc.
22. Flexcell International Corporation
23. Hill-Rom Holdings, Inc.
24. Hollister Incorporated
25. Kinetic Concepts, Inc.
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising